Drug · DIN 02284138
ADVATE
5ML DILUENT. ANTIHEMOPH.FACTOR (RECOMB.)PLASMA/ALBUMIN-FREE METHOD. SINGLE-DOSE VIALS
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since October 8, 2013; first marketed October 6, 2006.
- Drug Identification Number (DIN)
- 02284138
- Company (DIN owner)
- Baxter Healthcare CorporationDeerfield, Illinois, United States
- Schedule
- Schedule D
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Coagulation factor viii B02BD02
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ANTIHEMOPHILIC FACTOR (RECOMBINANT) | 250 UNIT | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 31, 2006: NOC 8187New Drug Submission (NDS)
Other DINs named ADVATE
- DIN 02284146 · Cancelled Post Market
- DIN 02284154 · Dormant
- DIN 02284162 · Dormant
- DIN 02313111 · Dormant
- DIN 02337193 · Dormant
- DIN 02365944 · Dormant
- DIN 02365952 · Dormant
- DIN 02365979 · Approved
- DIN 02365987 · Approved
- DIN 02446405 · Approved
- DIN 02446413 · Approved
- DIN 02446421 · Approved
- DIN 02446448 · Approved
- DIN 02446456 · Approved
- DIN 02446464 · Approved
- DIN 02446472 · Approved
- DIN 02446480 · Approved